Cancer News and Research

Latest Cancer News and Research

ASCOLT trial explores aspirin’s role in preventing colorectal cancer recurrence

A large-scale, international, multicentre, phase 3 clinical trial of aspirin for the secondary prevention of colorectal cancer has concluded.

17 Mar 2025

Current antivirals not successful in treating severe H5N1 bird flu infections

As the H5N1 avian influenza outbreak continues, scientists are working to better understand the virus's threat to human health.

17 Mar 2025

New research reveals potential path forward for glioblastoma treatment

Glioblastoma has remained one of the toughest cancers to treat, resisting even the latest advances in immunotherapy.

17 Mar 2025

Study finds link between mental health symptoms and increased nicotine use in youth

A recent study led by Emily Hackworth, a 2024 graduate of the Arnold School's Ph.D. in Health Promotion, Education, and Behavior, and co-authors has found that youth (ages 16-19) with internalizing mental health symptoms (e.g., anxiety, depression, sadness loneliness) are more likely to turn to nicotine products (particularly electronic cigarettes) than their peers.

17 Mar 2025

Neuropeptide Y identified as key driver of pancreatic cancer spread

Researchers at the Garvan Institute of Medical Research have uncovered how pancreatic cancer hijacks a crucial metabolism 'switch' to help it spread, revealing a potential new treatment strategy for this highly aggressive disease.

17 Mar 2025

Yale research supports MRD detection for post-treatment lung cancer care

In the continuing evolution of personalized medicine, a new Yale study has found evidence to support the value of a tool that measures the presence of cancer-derived molecules in the blood of patients with lung cancer years after their treatment.

17 Mar 2025

Experts release new guidelines on JAK inhibitors for chronic inflammatory diseases

Janus kinase inhibitors (JAKis) are an important treatment option for people with chronic inflammatory diseases such as rheumatoid arthritis, psoriasis, Crohn's disease or ulcerative colitis.

17 Mar 2025

Congenital heart defects may be linked to increased cancer risk in babies and mothers

Being born with a heart defect may be associated with an increased cancer risk for babies and their moms, according to new research published today in the American Heart Association's flagship journal Circulation.

17 Mar 2025

Scientist whose work led FDA to ban food dye says agency overstated risk

When the FDA announced in January, before President Joe Biden's term ended, that it would ban a dye called red dye No. 3 in food and ingested drugs, the federal agency cited just one 1987 study on rats to support its action.

17 Mar 2025

Scientists say NIH officials told them to scrub mRNA references on grants

National Institutes of Health officials have urged scientists to remove all references to mRNA vaccine technology from their grant applications, two researchers said, in a move that signaled the agency might abandon a promising field of medical research.

17 Mar 2025

White wine vs. red wine: Which poses a greater cancer risk?

A new meta-analysis finds no overall difference in cancer risk between red and white wine consumption, though white wine may raise skin cancer risk. Both wines are linked to higher breast cancer risk, debunking the myth that red wine is a "healthier" alcoholic choice.

16 Mar 2025

Polluted soil and water are fueling a global heart disease epidemic

A new study in Atherosclerosis shows that soil and water pollution, including microplastics and toxic chemicals, significantly raise cardiovascular disease risks. The research highlights how emerging contaminants and poor environmental practices drive global health threats.

16 Mar 2025

Nutri-Score proves effective, so why hasn’t the EU made it mandatory?

Experts call for an EU-wide, mandatory Nutri-Score label to promote healthier diets and curb industry influence on policymaking. The paper highlights how corporate lobbying has delayed EU action on front-of-pack nutrition labeling despite strong scientific evidence.

16 Mar 2025

Adding chemotherapy to radiotherapy does not improve outcomes for cervical cancer patients

Results from the NRG Oncology GOG-0263 phase III clinical trial testing the addition of cisplatin-based chemotherapy to adjuvant radiotherapy following radical hysterectomy and lymphadenectomy for patients with early-stage, intermediate-risk cervical carcinoma indicated that the addition of chemotherapy did not improve outcomes for patients and led to increased toxicity for patients.

14 Mar 2025

New approach to combat cancer by reactivating natural RNA kill switch

Alternative RNA splicing is like a movie editor cutting and rearranging scenes from the same footage to create different versions of a film.

14 Mar 2025

University of Minnesota awarded NIH grant for Alzheimer's cell therapy development

A University of Minnesota research team was recently awarded a five-year, $3.8 million grant from the U.S. National Institutes of Health to develop a new cell therapy to combat Alzheimer's disease.

14 Mar 2025

Fighting cancer, inflammation and unlocking dementia diagnostics

In recognition of their discovery of one of our immune system’s foundations, physician Andrea Ablasser, virologist Glen Barber and biochemist Zhijian J. Chen will be awarded the Paul Ehrlich and Ludwig Darmstaedter Prize 2025, endowed with €120,000, in Frankfurt’s Paulskirche today.

14 Mar 2025

Mitochondria may hold key to reducing inflammaging in aging cells

In humans and other multicellular organisms, cells multiply. This defining feature allows embryos to grow into adulthood, and enables the healing of the many bumps, bruises and scrapes along the way.

14 Mar 2025

Engineered nano-aircraft carrier enhances tumor targeting and immune response

The researchers designed an efficient approach for fabricating engineered Pts-based nano-aircraft carriers with graded drug delivery and ECM degradation for precise cancer chemoimmunotherapy.

14 Mar 2025

Combination of RAS inhibition and immunotherapy provides breakthrough for pancreatic cancer

Adding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept pancreatic cancer at bay in preclinical models for significantly longer than the same targeted therapy by itself, according to researchers from the Perelman School of Medicine at the University of Pennsylvania and Penn Medicine's Abramson Cancer Center.

14 Mar 2025

Previous
1
...
21
22
23
24
25
26
27
...
4490
Next

Cancer News and Research

Latest Cancer News and Research

ASCOLT trial explores aspirin’s role in preventing colorectal cancer recurrence

Current antivirals not successful in treating severe H5N1 bird flu infections

New research reveals potential path forward for glioblastoma treatment

Study finds link between mental health symptoms and increased nicotine use in youth

Neuropeptide Y identified as key driver of pancreatic cancer spread

Yale research supports MRD detection for post-treatment lung cancer care

Experts release new guidelines on JAK inhibitors for chronic inflammatory diseases

Congenital heart defects may be linked to increased cancer risk in babies and mothers

Scientist whose work led FDA to ban food dye says agency overstated risk

Scientists say NIH officials told them to scrub mRNA references on grants

White wine vs. red wine: Which poses a greater cancer risk?

Polluted soil and water are fueling a global heart disease epidemic

Nutri-Score proves effective, so why hasn’t the EU made it mandatory?

Adding chemotherapy to radiotherapy does not improve outcomes for cervical cancer patients

New approach to combat cancer by reactivating natural RNA kill switch

University of Minnesota awarded NIH grant for Alzheimer's cell therapy development

Fighting cancer, inflammation and unlocking dementia diagnostics

Mitochondria may hold key to reducing inflammaging in aging cells

Engineered nano-aircraft carrier enhances tumor targeting and immune response

Combination of RAS inhibition and immunotherapy provides breakthrough for pancreatic cancer

Cancer Research - Second Edition eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in